Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith transcript of conference call arranged by the Company with Analyst & Investors, on Thursday, 4th June, 2020 to discuss the financial result and performance of the Company for the quarter and year ended on 31st March, 2020. Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Investor Presentation
Further to our investor presentation and conference call dated 4th June, 2020, we would like to highlight some of the key financial parameters of our company for better understanding of all investors and other stakeholders. Kindly take the same on your record.
Earnings Call Transcript - Q4FY20 for Dishman Carbogen
Conference Call with Dishman Carbogen Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen to the full earnings transcript. Key Highlights Total Revenues at Rs 5,121.2 mn in Q4 FY 2020 down by 21.2% YoY CRAMS revenue decreased 18.4% YoY primarily due to: - CRAMS Carbogen Amcis AG revenue decreased by 11 %, attributable to higher revenues in the preceding quarters and certain commercial orders expected to be shipped in Q1 FY 2021 - CRAMS India revenue decreased by 29.8% YoY, due to Q4 FY2019 being an exceptional quarter due to exceptionally large commercial orders in that quarter. Most of the orders in FY2020 were evenly spread out throughout the year. - CRAMS UK – revenue decreased by 46.2% as its business is driven by demand of intermediates and starting materials of non-GMP products by customers, which would be very unevenly spread depending upon the requirement in that particular quarter. For the full year, CRAMS-UK revenue was in line with last year. EBITDA Margin at 25.8% in Q4 FY20, affected by: - Higher cost of material incurred in CRAMS India business due to increased cost of procurement from China, also took a one-time provision of certain inventory and forex movement. - Higher contribution of cholesterol segment, which typically have lower margin vs Vitamin D analogues - Other operating income included INR 80.3 mil foreign exchange gain on hedging in Q4 FY20 vs INR 290.8 mil gain in Q4 FY19 Adjusted PBT stands at Rs 819.3 mil & adjusted PAT stands at Rs 614.5 mil. Net debt as on March 31, 2020 stands at USD 100 mil vs USD 120 mil March 31, 2019 Finished goods inventory maintained at a higher level in Carbogen Amcis AG to fulfil the commercial product sales in upcoming quarters Capital expenditure for FY 2020 was approximately USD 42mn, which includes both growth and maintenance capex Foreign exchange gains in FY 2020 were Rs. 431.4 mn recorded as part of other operating income versus FX gains of Rs. 1,126.9 mn in FY 2019 In March 2020, two New Chemical Entities (NCEs) of our customers got approval from the regulatory agencies. Carbogen Amcis AG was the development partner for the APIs We have seen four NCEs getting various regulatory approvals in the last 12 months, where we were the development partner We continue to have a strong basket of about 20 APIs in Phase III development Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith Presentation on financial result for the quarter and year ended 31st March, 2020 to be made to Analyst and Investors. The aforesaid presentation is also being hosted on the website of the Company, www.dishmangroup.com in accordance with the Regulation 46 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Company has arranged Conference Call with Investors on Thursday, 4th June, 2020 at 16.00 hrs. (IST) to discuss the financial result and performance of the Company for the quarter and year ended on 31st March, 2020. The details of dial in numbers of Conference Call are attached herewith. Dishman Carbogen Amcis Ltd - 540701 - Results - Audited Financial Results For The March 31, 2020
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we hereby inform that a Meeting of the Board of Directors of the Company was held today i.e. on Wednesday, the 3rd day of June, 2020 which was commenced at 05.00 p.m. and concluded at 10.20 p.m., in the said Board Meeting, among others, agenda mentioned in attached letter were approved. Dishman Carbogen Amcis Ltd - 540701 - OUTCOME OF BOARD MEETING ALONGWITH AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS' AUDIT REPORT FOR THE QUARTER AND YEAR ENDED 31/03/2020
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we hereby inform that a Meeting of the Board of Directors of the Company was held today i.e. on Wednesday, the 3rd day of June, 2020 which was commenced at 05:00 p.m. and concluded at 10.20 p.m., in the said Board Meeting, among others, agenda mentioned in attached letter were approved. Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Intimation for Consideration Of Audited Financial Statements For The Quarter And Year Ended On 31St March, 2020.
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/06/2020 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2020.